Acibadem Healthcare Group
K. Fehmi Narter
Prof. M.D.

K. Fehmi Narter

Medical Units and Clinical Services
  • Andrology
  • Diagnosis and Treatment of Prostate Diseases
  • Treatment of Sexual Dysfunctions
  • Urethral Diseases Treatment
  • Urinary Incontinence and Bladder Health
  • Urology

Prof. K. Fehmi Narter is an experienced urologist and academic leader with a long-standing commitment to clinical care, research, and professional collaboration. He earned his Associate Professor (Doçent) title in 2012 and currently serves with Acibadem Health Group since 2020. Areas of expertise include urological surgery and uro-oncology, with active involvement in molecular medicine and advances in regenerative therapies. He has helped found several professional organizations focused on sexual health, physician support, and stem cell and gene therapy, reflecting a commitment to multidisciplinary progress and professional solidarity. Professional memberships: – Urological Surgery Association – Turkish Medical Association – Urooncology Association – Turkish Urology Association – European Association of Urology (EAU) – American Urological Association (AUA) – Molecular Medicine Association Founding roles: – Sexual Health and Education Association (Founding Member) – Physicians Legal Assistance and Solidarity Association (Founding Member) – Stem Cell and Gene Therapy Association (Founding Member) Former/Current leadership: – Presidency, Turkish Molecular Medicine Association His work bridges surgical practice, oncology, and molecular medicine, aiming to improve patient outcomes through evidence-based care, education, and collaboration across national and international professional communities.

Education

  • 2012 Associate Professor Doctor
  • 2008 – 2009 Istanbul Provincial Health Directorate Hospital Management / Business Administration Graduation Project: Legal limits of informed consent
  • 2002 – 2008 Istanbul University Experimental Medicine Research Center Molecular Medicine USA PhD; Phd, Molecular Medicine Doctor of Science
  • 1997 – 2002 Istanbul Police Hospital (Üsküdar State Hospital) / Urology Residency
  • 1999 – 2000 University of North Carolina Department of Urology / Visiting fellow USA
  • 1996 Haydarpasa Numune Training and Research Hospital Urology
  • 1989 Istanbul University Istanbul Faculty of Medicine

Experience

  • 2020 Acibadem Health Group
  • 2013 – 2017 Kartal Dr. Lütfi Kırdar Training and Research Hospital Urology Specialist / Education Officer
  • 1997 – 2013 Üsküdar State Hospital
  • 2002 – 2012 Üsküdar State Hospital / Urology Residency and Deputy Chief Physician
  • 1997 – 1999 Gölcük Naval Forces Hospital Urology Specialist / Military service
  • 1989 – 1991 Gökçeyazı Health Center Medicine / Compulsory service

Memberships

  • Urological Surgery Association
  • Turkish Medical Association
  • Urooncology Association
  • Turkish Urology Association
  • European Association of Urology (EAU)
  • Founding Member of Sexual Health and Education Association
  • Founding Member of Physicians Legal Assistance and Solidarity Association
  • Founding Member of Stem Cell and Gene Therapy Association
  • Presidency of Turkish Molecular Medicine Association
  • American Urological Association (AUA)
  • Molecular Medicine Association

Publications

  • Urethral Foreign Body: Evaluation of an Interesting Case with Literature
    TR 2016;27(2): 158-160. Cahit Sahin, Mehmet Kutlu Demirkol, Fehmi Narter, Bilal Eryildirim, Kemal Sarica. J Kartal
  • The importance of re-transurethral resection in the treatment of bladder cancer.
    Uroonkoloji Bulletin 2016,15, 94-97. Fehmi Narter, Fatih Tarhan, Erkin Saglam, Gokhan Faydaci, Kutluhan Erdem, Övünç Kavukoğlu, Emre Çamur
  • Genetic factors in bladder cancer.
    Turkish Cancer Foundation, Bladder Cancer special issue, 2016, 4/4; 13-19. Fehmi Narter.
  • Presence and thickness of false capsule in renal cancer patients undergoing partial nephrectomy.
    Uroonkoloji Bulletin 2016, 15; 136-139 Fehmi Narter, Fatih Tarhan, Emre Çamur, Şükran Sarıkaya, Kayhan Başak. Murat Tuncer, İstem Köse, Aydın Özgül
  • Invasion mechanisms of the bladder cancer: A molecular review.
    Journal of Urological Surgery, 2016; 3: 66-73 Fehmi Narter, Kubilay Sabuncu
  • Molecular Factors in the Genesis of Kidney Cancers: What is the Basis for Targeted Therapy?
    Turkish Cancer Foundation, Kidney Cancer special issue, June 2015, vol 3/2, 11-23. Fehmi Narter, Ayşe Özer.
  • Urinary Stones in Neonates; Dilemma between urolithiasis and nephrocalcinosis
    Journal of Urological Surgery, 2015; 1: 1-6 Fatma Narter, K.F. Narter, K.Sarıca.
  • How I do it: Radical Perineal Prostatectomy.
    Journal of Urological Surgery, 2015; 2: 111-115 Cemal Göktaş, A. Cihangir Çetine], K. Fehmi Narter.
  • Screening for bladder cancer: Relevance and limitations. ”Screening for Bladder Cancer: Reliability and limitations
    K.F.Narter, C. Sahin Urooncology Bulletin Urooncology Bulletin 2015; 14: 38-45
  • Molecular and genetic mechanisms in bladder cancer.
    Türkiye Klinikleri J Urology-Special Topics 2014;7(2):5-16 F.Narter, C.Çetinel,





×
Logo

29 hospitals and 15 medical centers in 5 countries.

About Us
Hospitals
Treatments
Doctors
Medical Technologies
Check Up Packages
Appointment
Blog
Contact
Contact Us
Promotional
About Us

At ACIBADEM Healthcare Group, we are committed to healthcare excellence and providing world-class healthcare services to our patients. As a leader in international healthcare, we strive to deliver the highest quality of care and meet the needs of our diverse patient population.

Read More...
Appointment FormLive Support
Manage your privacy

We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.

Functional
Always active
Preferences
Statistics